Proactive Investors - Run By Investors For Investors

IXICO CEO Giulio Cerroni on record revenues and significant contract extension

Giulio Cerroni, chief executive of IXICO PLC (LON:IXI), caught up with Proactive London's Andrew Scott to discuss their results for the year to the end of September as well as the expansion to a contract.

The scope of a current contract with a top 10 biopharmaceutical company has been enlarged, increasing the value by US$2.4mln over the remaining six-year term of the agreement to US$5.1mln.

Where IXICO's results are concerned revenue rose 32% to £5.39mln from £4.10mln the year before, while the gross margin improved to 58.8% from 56.4%.

The loss before tax narrowed to £793,000 from £1.91mln the previous year.

Meet MaxCyte, Primary Health Properties PLC, Scancell Holdings PLC and PCF Group Plc at our event, London , 25 April 2019. Register here »
View full IXI profile View Profile

IXICO PLC Timeline

December 11 2018

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use